Skip to content
Study details
Enrolling now

Exercise for Cognitive Excellence in Parkinson's Disease

University of California, San Francisco
NCT IDNCT05720468ClinicalTrials.gov data as of Apr 2026
Target enrollment

32

Study length

about 2.5 years

Ages

40–80

Locations

1 site in CA

About this study

Researchers are testing a home-based exercise program to see if it improves cognition and other health markers in people with Parkinson's disease. The trial will also assess the safety of this type of treatment.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Exercise
  • 2.No Exercise
Primary goalAverage percent heart rate maximum (HR max)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low12%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Average percent heart rate maximum (HR max)

Secondary: Change in biomarker of aging, Change in biomarker of inflammation, Change in biomarker of stress, Change in cognitive function, Change in motor symptoms of Parkinson's disease, Change in neurotrophic biomarker

Body systems

Neurology